Lōkahi Therapeutics Advances Lt-100 Development Strategy Toward Single-Injection Administration
GCTK•Lōkahi Therapeutics advances Lt-100 strategy
July 29 (Reuters) - GlucoTrack Inc GCTK.O:
- Lōkahi Therapeutics advances Lt-100 development strategy toward single-injection administration
- Lōkahi Therapeutics anticipates clinical evaluation of single-injection Lt-100 as early as Q4 2026
